Drug Type Bispecific antibody |
Synonyms 4-1BB costimulator/anti-tumor associated antigen conditional bispecific antibody (ABL Bio) |
Target |
Action agonists |
Mechanism 4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | South Korea | 10 Apr 2021 |